Patents by Inventor Connie L. Erickson-Miller

Connie L. Erickson-Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of use of sialoadhesin factor-2 antibodies
    Patent number: 7871612
    Abstract: Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2. These antibodies are useful as diagnostic and therapeutic reagents.
    Type: Grant
    Filed: October 12, 2006
    Date of Patent: January 18, 2011
    Assignee: The Johns Hopkins University
    Inventors: Julie A. Abrahamson, Connie L Erickson-Miller, Kristine K. Kikly, Bruce Bochner, Robert Schleimer, T. Esra Nutku
  • THROMBOPOIETIN RECEPTOR AGONIST (TPORA) KILLS ACUTE HUMAN MYELOID LEUKEMIA CELLS
    Publication number: 20100298398
    Abstract: The present invention provides methods of inhibiting human myeloid leukemia cell growth and proliferation by administering a thrombopoietin receptor agonist (TpoRA), a derivative, or variant thereof, to an individual with AML.
    Type: Application
    Filed: October 8, 2008
    Publication date: November 25, 2010
    Inventors: Alan Gewirtz, Anna Kalota, Connie L. Erickson-Miller
  • SIALOADHESIN FACTOR-2 ANTIBODIES
    Publication number: 20100056760
    Abstract: Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2. These antibodies are useful as diagnostic and therapeutic reagents.
    Type: Application
    Filed: May 29, 2009
    Publication date: March 4, 2010
    Applicant: SmithKline Beecham Corporation
    Inventors: Julie A. ABRAHAMSON, Connie L. Erickson-Miller, Kristine K. Kikly, Bruce Bochner, Robert Schleimer, T. Esra Nutku
  • Novel Combinations
    Publication number: 20090304634
    Abstract: Invented is a method of treating viral diseases, particularly hepatitis C, in a human, in need thereof which comprises the administration of a combination of therapeutically active agents selected from a TPO receptor agonist and an antiviral therapy selected from: an alpha interferon, ribavirin, a ribavirin analog and an HCV antiviral to such human.
    Type: Application
    Filed: December 10, 2007
    Publication date: December 10, 2009
    Inventors: Connie L Erickson-Miller, Julian Jenkins, Dickens Theodore
  • Sialoadhesin factor-2 antibodies
    Patent number: 7557191
    Abstract: Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2. These antibodies are useful as diagnostic and therapeutic reagents.
    Type: Grant
    Filed: October 12, 2006
    Date of Patent: July 7, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Julie A. Abrahamson, Connie L Erickson-Miller, Kristine K. Kikly, Bruce Bochner, Robert Schleimer
  • Sialoadhesin factor-2 antibodies
    Publication number: 20080213212
    Abstract: Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2.
    Type: Application
    Filed: October 12, 2006
    Publication date: September 4, 2008
    Inventors: Julie A. Abrahamson, Connie L. Erickson-Miller, Kristine K. Kikly, Bruce Bochner, Robert Schleimer, T. Esra Nutku
  • Erythropoietin receptor antibodies
    Patent number: 6998124
    Abstract: Erythropoietin receptor agonist and antagonist antibodies and their use in enhancing erythropoiesis are disclosed.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: February 14, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Connie L. Erickson-Miller, Stephen D. Holmes, Alexander H. Taylor, Peter R. Young
  • Sialoadhesin factor-2 antibodies
    Publication number: 20030092091
    Abstract: Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2.
    Type: Application
    Filed: August 29, 2002
    Publication date: May 15, 2003
    Inventors: Julie A. Abrahamson, Connie L. Erickson-Miller, Kristine K. Kikly, Bruce Bochner, Robert Schleimer, T. Esra Nutku
  • Tie2 antagonist antibodies
    Patent number: 6376653
    Abstract: Tie2 receptor antagonist antibodies, their use in inhibiting angiogenesis and other uses are disclosed.
    Type: Grant
    Filed: September 27, 1999
    Date of Patent: April 23, 2002
    Assignees: SmithKline Beecham plc, SmithKline Beecham Corporation
    Inventors: Stephen D. Holmes, Connie L. Erickson-Miller, James D. Winkler
  • Tie2 agonist antibodies
    Patent number: 6365154
    Abstract: Tie2 receptor agonist antibodies, their use in enhancing angiogenesis and other uses are disclosed.
    Type: Grant
    Filed: September 27, 1999
    Date of Patent: April 2, 2002
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham p.1.c.
    Inventors: Stephen D. Holmes, Connie L. Erickson-Miller, James D. Winkler
  • Erythropoietin receptor antibodies
    Patent number: 6153190
    Abstract: Monoclonal antibodies to the erythropoietin receptor are disclosed.
    Type: Grant
    Filed: January 23, 1997
    Date of Patent: November 28, 2000
    Inventors: Peter Ronald Young, Connie L. Erickson-Miller